Literature DB >> 16146848

CC chemokine receptor 4-positive diffuse large B-cell lymphoma involving the skin: a case report.

Takashi Ishida1, Hiroshi Inagaki, Shigeru Kusumoto, Atsushi Inagaki, Hirokazu Komatsu, Shinsuke Iida, Shinsuke Harada, Genji Takeuchi, Ryuzo Uedaa.   

Abstract

Leukocyte trafficking is critically regulated by chemokines and their receptors. The involvement of the skin in certain subsets of T-cell malignancies has been explained by the discovery of an interaction between the thymus and activation-regulated chemokine (TARC), which is abundant in the skin, and its receptor, CC chemokine receptor 4 (CCR4), which is expressed in the tumor cells. We describe a diffuse large B-cell lymphoma (DLBCL) that showed CCR4 expression with involvement of the skin. A 55-year-old man presented with a giant skin ulcer of the right axilla, and his disease was diagnosed as DLBCL. Further clinical examination revealed an ulcerated gastric lymphoma lesion. Immunohistochemical and real-time reverse transcriptase-polymerase chain reaction analyses showed that the tumor cells were positive for CCR4, and TARC was expressed at extremely high levels in the lymphoma-affected skin. These observations suggest that the interaction between CCR4 and TARC played a significant role in the involvement of the skin in this case, similar to what has been observed in certain subsets of T-cell malignancies. To the best of our knowledge, this report is the first of a CCR4-positive B-cell lymphoma. The present case provides new insights into the pathogenesis of skin involvement in B-cell lymphomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16146848     DOI: 10.1532/IJH97.04154

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  15 in total

Review 1.  Lymphocyte trafficking and regional immunity.

Authors:  E C Butcher; M Williams; K Youngman; L Rott; M Briskin
Journal:  Adv Immunol       Date:  1999       Impact factor: 3.543

2.  The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells.

Authors:  J J Campbell; G Haraldsen; J Pan; J Rottman; S Qin; P Ponath; D P Andrew; R Warnke; N Ruffing; N Kassam; L Wu; E C Butcher
Journal:  Nature       Date:  1999-08-19       Impact factor: 49.962

Review 3.  Chemokines in tissue-specific and microenvironment-specific lymphocyte homing.

Authors:  J J Campbell; E C Butcher
Journal:  Curr Opin Immunol       Date:  2000-06       Impact factor: 7.486

Review 4.  The pathogenesis of mycosis fungoides.

Authors:  Michael Girardi; Peter W Heald; Lynn D Wilson
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

5.  Involvement of chemokine receptors in breast cancer metastasis.

Authors:  A Müller; B Homey; H Soto; N Ge; D Catron; M E Buchanan; T McClanahan; E Murphy; W Yuan; S N Wagner; J L Barrera; A Mohar; E Verástegui; A Zlotnik
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

6.  Cutaneous lymphocyte-associated antigen (CLA) expression in a lymphoblastoid mantle cell lymphoma presenting with skin lesions. Comparison with other clinicopathologic presentations of mantle cell lymphoma.

Authors:  R M Martí; E Campo; F Bosch; J Palou; T Estrach
Journal:  J Cutan Pathol       Date:  2001-05       Impact factor: 1.587

7.  Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine.

Authors:  T Imai; M Nagira; S Takagi; M Kakizaki; M Nishimura; J Wang; P W Gray; K Matsushima; O Yoshie
Journal:  Int Immunol       Date:  1999-01       Impact factor: 4.823

8.  The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4.

Authors:  T Imai; M Baba; M Nishimura; M Kakizaki; S Takagi; O Yoshie
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

9.  Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome.

Authors:  Takashi Ishida; Atae Utsunomiya; Shinsuke Iida; Hiroshi Inagaki; Yoshifusa Takatsuka; Shigeru Kusumoto; Genji Takeuchi; Shigeki Shimizu; Masato Ito; Hirokazu Komatsu; Atsushi Wakita; Tadaaki Eimoto; Kouji Matsushima; Ryuzo Ueda
Journal:  Clin Cancer Res       Date:  2003-09-01       Impact factor: 12.531

10.  Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma.

Authors:  Rinpei Niwa; Emi Shoji-Hosaka; Mikiko Sakurada; Toyohide Shinkawa; Kazuhisa Uchida; Kazuyasu Nakamura; Kouji Matsushima; Ryuzo Ueda; Nobuo Hanai; Kenya Shitara
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

View more
  1 in total

1.  The human cutaneous chemokine system.

Authors:  Michelle L McCully; Bernhard Moser
Journal:  Front Immunol       Date:  2011-08-09       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.